Financhill
Back

Apellis Pharmaceuticals Vs. Agilysys, Industry Stock Comparison

Buy
65

APLS
Apellis Pharmaceuticals

Last Price:
$27.62
Seasonality Move:
-1.34%
Sell
50

AGYS
Agilysys,

Last Price:
$106.22
Seasonality Move:
-1.03%
Buy
65
Apellis Pharmaceuticals (APLS) is a Buy

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $26.58. The Score for APLS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Agilysys, (AGYS) is a Sell

Is Agilysys, a Buy, Sell or Hold?

  • The current Agilysys, [AGYS] share price is $110.91. The Score for AGYS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • AGYS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $26.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

AGYS Stock Price Chart

What is Agilysys,'s stock price today?

  • The Agilysys, share price today is $110.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.61 Buy
Relative Strength Index (14 RSI): 77.42 Buy
Chaikin Money Flow: 4352933 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.01 - 23.67) Buy
Bollinger Bands (100): (17.24 - 21.88) Buy

AGYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.9 Sell
Relative Strength Index (14 RSI): 47.61 Sell
Chaikin Money Flow: 106212 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.26 - 117.64) Sell
Bollinger Bands (100): (77.19 - 115.23) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.4 Buy
20-day SMA: 21.77 Buy
50-day SMA: 19.86 Buy
200-day SMA: 24.53 Buy
8-day EMA: 24.15 Buy
20-day EMA: 22.39 Buy
50-day EMA: 20.76 Buy
200-day EMA: 24.97 Buy

AGYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.28 Sell
20-day SMA: 113.87 Sell
50-day SMA: 113.17 Sell
200-day SMA: 103.01 Buy
8-day EMA: 110.51 Buy
20-day EMA: 112.41 Sell
50-day EMA: 109.56 Buy
200-day EMA: 101.34 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.18 per share, a decrease next quarter of $1.21 per share, an increase this year of $1.33 per share, and a decrease next year of $0.70 per share.

Agilysys, Earnings Growth & AGYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.03 per share, an increase this year of $0.25 per share, and an increase next year of $0.33 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Agilysys, Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):